2Giangaspero F, Cenacchi G, Roncaroli F, et al. Medulloblastoma ( Lipdized medulloblastome ) :a cerebellar neoplasm of adults with favorable progonosis. Am J Surg pathol, 1996, 20: 656-664.
3Katsetos CD, Krishnal L, Frankfurter A, et al. A cytomorphological scheme of differentiating neuronal phenotypes in cerebellar medulloblastoma based on immunolocalization of class Ⅲ beta-tubulin isotype ( beta Ⅲ ) and proliferation cell nuclear antigen
4Hall PA, Levison PA, Woods AL, et al. Proliferation cell nuclear antigen ( PCNA ) immolocalizatin in paraffin section: An index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol, 1990, 162: 285-294.
5Miettinen H, Kononen J, Sallinen P, et al. CDKN2/p16 predicts survival in oligodendrogliomas: comparison with astrocytomas. J Neurooncol,1999, 41: 205-211.
6Gugger M, Kappeler A, Vonlanthen S,et al.Alterations of cell cycle regulators are less frequent in advanced non-small cell lung cancer than in resectable tumours. Lung Cancer, 2001, 33: 229-239.
7Seemann N, Kuhn D, Wrocklage C, et al.CDKN2A/p16 inactivation is related to pituitary adenoma type and size.J Pathol, 2001, 193:491-497.
8Korshunov A, Golanov A, Ozerov S, et al. Prognostic value of tumor-associated antigens immunoreactivity and apoptosis in medulloblastomas. An analysis of 73 cases. Brain Tumor Pathol, 1999,16( 1 ): 37.
9Stavrou T, Bromley CM, Nicholson HS, et al. Prognostic factors and secondary malignancies in childhood medulloblastoma. Pediatr Hematol Oncol, 2001, 23(7):431.
10Kunschner L J, Kuttesch J, Hess K, et al. Survival and recurrence factors in adult medulloblastoma: the M.D. Anderson Cancer Center experience from 1978 to 1998. Neuro Oncol,2001,3(3):167.
